Genmab (Otc) (GMAB)

NASDAQ:GMAB

US Market

GMAB

Genmab

RESEARCH TOOLSreports

Want to see GMAB full AI Analyst Report?

Genmab (GMAB) Ownership - Who Owns Genmab?

777 Followers

Genmab (GMAB) Ownership Overview

0.84% Mutual Funds

5.67% Other Institutional Investors

1.17% ETFs

92.33% Public Companies and

Individual Investors

The ownership structure of Genmab (GMAB) stock is a mix of institutional, retail, and individual investors. Approximately 7.67% of the company’s stock is owned by Institutional Investors, and 92.33% is owned by Public Companies and Individual Investors.

The ownership structure of Genmab (GMAB) stock is a mix of institutional, retail, and individual investors. Approximately 6.84% of the company’s stock is owned by Institutional Investors, 0.84% is owned by Insiders, and 92.33% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Moore Capital Management Lp	xxxxxxxxxxxxx	$5680045
Mar 31, 2024	Manning & Napier Advisors Llc	xxxxxxxxxxxxx	$1449
Mar 31, 2024	Deerfield Management Company, Lp	xxxxxxxxxxxxx	$66055460
Mar 31, 2024	Gallacher Capital Management Llc	xxxxxxxxxxxxx	$584814

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	3,605,746	Institution	0.58%	98,112,349
	2,825,032	Institution	0.45%	76,869,121
James E. Flynn	2,462,000	Institution	0.39%	66,991,020
	2,337,110	Institution	0.37%	63,592,763
	870,700	Institution	0.14%	23,691,747
	535,103	Institution	0.09%	14,560,153
	414,116	Institution	0.07%	11,268,096
Michael Rockefeller	369,188	Institution	0.06%	10,045,605
	362,815	Institution	0.06%	9,872,196
	258,730	Institution	0.04%	7,040,043

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value
	2,337,110	Institution	0.37%	63,592,763
	870,700	Institution	0.14%	23,691,747
	414,116	Institution	0.07%	11,268,096
	362,815	Institution	0.06%	9,872,196
	258,730	Institution	0.04%	7,040,043
	195,954	Institution	0.03%	5,331,908
	179,676	Institution	0.03%	4,888,984
	179,130	Institution	0.03%	4,874,127
	142,000	Institution	0.02%	3,863,820
	47,510	Institution	<0.01%	1,292,747

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Biotechnology ETF	3,514,902	Institution	0.56%	95,218,695
First Trust NYSE Arca Biotechnology Index Fund	2,734,409	Institution	0.44%	74,075,140
Avantis International Equity ETF	494,783	Institution	0.08%	12,953,419
Tema Oncology ETF	185,324	Institution	0.03%	4,851,782
First Trust Hedged BuyWrite Income ETF	73,374	Institution	0.01%	1,987,702
iShares NASDAQ US Biotechnology UCITS ETF	45,422	Institution	<0.01%	1,189,148
ActivePassive International Equity ETF	36,178	Institution	<0.01%	947,140
Fidelity Enhanced International ETF	34,697	Institution	<0.01%	908,367
Fidelity Nasdaq Composite Index ETF	25,835	Institution	<0.01%	676,360
Avantis International Large Cap Value ETF	17,483	Institution	<0.01%	457,705

FAQ

Who Owns Genmab (Otc) (GMAB)?

Currently, no data Available

What percentage of Genmab (Otc) (GMAB) stock is held by institutional investors?

According to the latest TipRanks data, approximately 5.67% of Genmab (Otc) (GMAB) stock is held by institutional investors.

What percentage of Genmab (Otc) (GMAB) stock is held by retail investors?

According to the latest TipRanks data, approximately 92.33% of Genmab (Otc) (GMAB) stock is held by retail investors.

Who owns the most shares of Genmab (Otc) (GMAB)?

iShares owns the most shares of Genmab (Otc) (GMAB).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.